| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |